Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1371815 | Bioorganic & Medicinal Chemistry Letters | 2012 | 4 Pages |
Abstract
Monoamine oxidase-B (MAO-B) inhibitor has been used as neuroprotectants to treat the motor deficits of Parkinson‘s disease (PD). We designed and synthesized a class of 8-substituted benzamido-phenylxanthine derivatives as MAO-B inhibitors. The compounds have various inhibitory effects, with compound 6a having a Ki value of 0.26 μM. Their promising activity in vitro suggests potential use in the treatment of PD.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Bo Song, Tong Xiao, Xiaolu Qi, Ling-Na Li, Kuiyou Qin, Siyun Nian, Guo-Xin Hu, Yinfei Yu, Guang Liang, Faqing Ye,